Xiaoming Zha Selected Research

Albumin-Bound Paclitaxel

11/2023	Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer.
1/2023	Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response.
1/2023	Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer.
1/2022	Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer.
1/2021	Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer.
1/2019	Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoming Zha Research Topics

Disease

36	Breast Neoplasms (Breast Cancer) 05/2024 - 12/2011
23	Neoplasms (Cancer) 04/2024 - 05/2012
10	Secondary Hyperparathyroidism 11/2021 - 08/2013
9	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2012
7	Chronic Renal Insufficiency 12/2023 - 01/2016
4	Triple Negative Breast Neoplasms 01/2023 - 08/2012
3	Pathologic Complete Response 01/2022 - 12/2021
3	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 07/2018 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2018 - 08/2013
2	Glioma (Gliomas) 04/2024 - 01/2018
2	Anemia 12/2023 - 01/2016
2	Metabolic Bone Diseases (Osteopenia) 12/2023 - 08/2019
2	Inflammation (Inflammations) 06/2022 - 07/2020
2	Hypocalcemia 10/2019 - 12/2018
2	Bone Resorption 08/2019 - 12/2018
2	Malnutrition (Nutritional Deficiencies) 07/2018 - 01/2016
1	Febrile Neutropenia 01/2023
1	Neutropenia 01/2023
1	Abscess 06/2022
1	Fistula 06/2022
1	Ductal Carcinoma 05/2021
1	Cardiac Arrhythmias (Arrythmia) 09/2020
1	Infections 09/2020
1	Thrombosis (Thrombus) 09/2020
1	Breast Diseases (Breast Disease) 07/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019
1	Hyperparathyroidism 10/2019
1	Hyperkalemia 10/2019
1	Disease Progression 03/2019
1	Hyperplasia 07/2018
1	Pain (Aches) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Acute Promyelocytic Leukemia 01/2018

Drug/Important Bio-Agent (IBA)

6	Albumin-Bound Paclitaxel FDA Link 11/2023 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2012
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 07/2020 - 12/2012
4	Hormones (Hormone)IBA 08/2019 - 09/2014
3	Docetaxel (Taxotere)FDA Link 11/2023 - 01/2021
3	SolventsIBA 11/2023 - 01/2019
3	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 01/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2012
3	Histones (Histone)IBA 12/2019 - 01/2018
3	Lysine (L-Lysine)FDA Link 01/2018 - 01/2017
3	LeptinIBA 01/2016 - 02/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024 - 12/2019
2	Taxoids (Taxanes)IBA 11/2023 - 01/2023
2	AnthracyclinesIBA 01/2023 - 12/2012
2	taxaneIBA 01/2023 - 01/2012
2	Parathyroid Hormone (Parathormone)IBA 11/2021 - 12/2018
2	Phenobarbital (Luminal)FDA Link 05/2021 - 01/2012
2	Tartrate-Resistant Acid PhosphataseIBA 08/2019 - 12/2018
2	CalciumIBA 12/2018 - 07/2018
2	BiguanidesIBA 01/2017 - 01/2015
2	Estrogens (Estrogen)FDA Link 01/2017 - 02/2013
1	Vitamin D FDA LinkGeneric 05/2024
1	Transfer RNA (tRNA)IBA 05/2024
1	25-hydroxyvitamin DIBA 05/2024
1	hydroxide ionIBA 05/2024
1	RNA (Ribonucleic Acid)IBA 05/2024
1	Nicotinamide PhosphoribosyltransferaseIBA 04/2024
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	Hemoglobins (Hemoglobin)IBA 12/2023
1	human ERBB2 proteinIBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023
1	pegylated granulocyte colony-stimulating factorIBA 01/2023
1	Large Neutral Amino Acid-Transporter 1IBA 01/2022
1	ElementsIBA 12/2021
1	Small Interfering RNA (siRNA)IBA 12/2021
1	AntigensIBA 07/2020
1	Carcinoembryonic AntigenIBA 07/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2020
1	Long Noncoding RNAIBA 01/2020
1	PotassiumIBA 10/2019
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 08/2019
1	Collagen Type I (Type I Collagen)IBA 08/2019
1	OsteocalcinIBA 08/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Fibroblast Growth Factor-23IBA 12/2018
1	Alkaline PhosphataseIBA 12/2018
1	DioxygenasesIBA 10/2018
1	Therapeutic UsesIBA 07/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	SirtuinsIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018

Therapy/Procedure

14	Parathyroidectomy 12/2023 - 08/2013
11	Neoadjuvant Therapy 11/2023 - 01/2019
6	Therapeutics 03/2023 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
2	Mastectomy (Mammectomy) 01/2023 - 11/2019
2	Segmental Mastectomy (Lumpectomy) 11/2019 - 01/2013
2	Renal Dialysis (Hemodialysis) 10/2019 - 12/2018
1	Emergency Treatment 01/2023
1	Adjuvant Chemotherapy 01/2022
1	Modified Radical Mastectomy (Mastectomy, Modified) 05/2021
1	Catheters 09/2020
1	Oral Administration 12/2019
1	Autologous Transplantation 08/2019
1	Peritoneal Dialysis 03/2019